Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis
Clinical trial NCT02280616 · COMPLETED
Trial details
- NCT number
- NCT02280616
- Sponsor
- Dr. Falk Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-04-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.